Federal Register of Legislation - Australian Government

Primary content

PB 37 of 2019 Determinations/Health as made
This instrument amends Schedule 3 of the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008) to include additions, deletions and changes to drugs and forms.
Administered by: Health
Registered 30 May 2019
Tabling HistoryDate
Tabled Senate02-Jul-2019
Tabled HR02-Jul-2019
To be repealed 17 Sep 2019
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

PB 37 of 2019

 

National Health Determination under paragraph 98C(1)(b) Amendment 2019 (No. 4)

 

National Health Act 1953

___________________________________________________________________________

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated                                                                  24 May        2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health


___________________________________________________________________________

1          Name of Instrument

(1)          This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2019 (No. 4).

(2)          This Instrument may also be cited as PB 37 of 2019.

2          Commencement

This Instrument commences on 1 June 2019.

3          Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

 


Schedule 1     Amendments

[1]        Schedule 3, entry for Hydromorphone

omit:

 

Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 473 mL